Which just goes to show the irrationality of the s
Post# of 145194
![](/assets/46931549/no_avatar_available_thumb.jpg)
Between February of 2017 and July 2018 MTNB went from $3.74 to .35 cents a share.
MAT9001 has done very little so far so I don't expect much from the new trial either. The deal they set up is very unproductive if they don't hit milestones. Where do you think MTNB will be a year from now versus Cytodyn?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)